11 Mar 2016
Results of a clinical trial of patients with HER2-positive breast cancer were presented at the European Breast Cancer Conference in Amsterdam. Patients treated with a combination of herceptin plus lapatinib showed significantly decreased tumour mass.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024